News
Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help ...
Researchers have found in phase 3 ORIGIN 3 trial that investigational dual BAFF/APRIL inhibitor atacicept significantly ...
Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial ...
From the practical wisdom of emphasising exercise to improve survival in colon cancer to the association of glucagon-like ...
In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...
Erika Hamilton, MD, discusses the mechanism of action of emiltatug ledadotin, a B7-H4-directed Dolasynthen antibody-drug conjugate.
NICE decided that two Alzheimer’s drugs are too expensive for their modest benefits and cannot be recommended for NHS use in ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...
12h
Pharmaceutical Technology on MSNGilead Sciences’ Yeztugo receives approval from US FDA for HIVThis is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthrou ...
The adaptive, biomarker-directed trial allows researchers to enrich for best responders and open new sub-studies for non-responders based on emerging data.
THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results